James Edward Wooldridge MD

Physician

Checkmate PharmaceuticalsCambridge, MA 02142

Dr. Wooldridge is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Wooldridge's full profile Already have an account?

Education & Training

University of Iowa Health Care Medical CenterFellowship, Hematology and Medical Oncology, 1996 - 1999
University of Iowa Health Care Medical CenterResidency, Internal Medicine, 1992 - 1996
Tulane University School of MedicineClass of 1992

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

MO State Medical License 1999 - 2027

Publications & Presentations

PubMed

63 citations
Neoadjuvant vidutolimod and nivolumab in high-risk resectable melanoma: A prospective phase II trial.
Diwakar Davar, Robert M Morrison, Amiran K Dzutsev, Arivarasan Karunamurthy, Joe-Marc Chauvin
Cancer Cell. 2024-11-11
6 citations
Vidutolimod in Combination With Atezolizumab With and Without Radiation Therapy in Patients With Programmed Cell Death Protein 1 or Programmed Death-Ligand 1 Blockade-...
Marcelo V Negrao, Vassiliki A Papadimitrakopoulou, Andrew C Price, Alda L Tam, Muhammad Furqan
JTO Clinical and Research Reports. 2023-03-01
133 citations
Overcoming PD-1 Blockade Resistance with CpG-A Toll-Like Receptor 9 Agonist Vidutolimod in Patients with Metastatic Melanoma.
Antoni Ribas, Theresa Medina, John M. Kirkwood, Yousef Zakharia, Rene Gonzalez
Cancer Discovery. 2021-07-29

Press Mentions

Immunitas Therapeutics Announces First Patient Dosed in Phase 1/2a Study of IMT-009January 4th, 2023
Checkmate Pharmaceuticals Announces Additions to Management TeamOctober 15th, 2019

Grant Support

CPG 7909 In Previously Treated Chronic Lymphocytic LeukemiaNational Center For Research Resources2005–2006

Professional Memberships

American Society of Clinical Oncology - ASCO
Member
American Society of Hematology - ASH
Member
American Association for Cancer Research - AACR
Member

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Similar Physicians & HCPs

Ryan Sullivan, MD
OncBoston, MA
Jeremy Abramson, MD
OncBoston, MA
Rebecca (Suk) Heist, MD
OncBoston, MA
Jeffrey Clark, MD
OncBoston, MA
Jill Allen, MD
OncBoston, MA
Jeffrey Jones, MD
OncCambridge, MA
Jeffrey Peppercorn, MD
OncBoston, MA
Priscilla Brastianos, MD
OncBoston, MA
Cynthia Sirard, MD
OncCambridge, MA
Frank Hsu, MD
OncCambridge, MA

Doximity / States / Massachusetts / Cambridge / James Wooldridge, MD

Dr. James Wooldridge, Dr. James Wooldridge, MD, Dr. J Wooldridge, Dr. James Edward Wooldridge